Neeraj Gupta

Statistics

Publications

Citations

4.3K

H-Index

Active since

1991

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

Mayo Clinic in Arizona

Dana-Farber Cancer Institute

Takeda (Japan)

Neeraj Gupta is an author at Millennium Engineering and Integration (United States) specializing in medicine, pharmacology, and clinical pharmacology.

ORCID

Publications per year

1991–2024

Publications

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer

D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2018 · 976 citations · Full text

Medicine, Oncology, Pharmacology +13

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn et al. · Journal of Clinical Oncology · 2020 · 367 citations · Full text

Medicine, Oncology, Pharmacology +16

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

Shaji Kumar, Jesús G. Berdeja, Rubén Niesvizky et al. · The Lancet Oncology · 2014 · 265 citations

Medicine, Oncology, Pharmacology +14

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients

Paul G. Richardson, Rachid Baz, Michael Wang et al. · Blood · 2014 · 202 citations · Full text

Medicine, Hematology, Pharmacology +15

1–5 of 77